Morning Market Losers By: Benzinga via Benzinga March 30, 2015 at 09:49 AM EDT Can-Fite BioPharma Ltd. (NYSE: CANF) shares dipped 49.82% to $2.78 following news that top-line results from Phase II/III trial for ... Read More >> Related Stocks: Adamis Pharmaceuticl Altera Corp American Shared Hospital Services Biodelivery Sci Intl Can-Fite Biopharma Ltd ADR Intel Corp Mylan P F Inds Inc A Pan American Silver Corp.